Piper Jaffray Downgrades ATS Medical (ATSI) to Neutral; Q1 Light, But Moot; Reduced Likelihood of Competitive Bid
ATSI Hot Sheet
Rating Summary:0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 23
Piper Jaffray downgrades ATS Medical, Inc. (Nasdaq: ATSI) from Overweight to Neutral.
Piper analyst says, "ATS Medical reported Q1 sales of $18.6M, which were a little light relative to our expectations both in terms of sales and earnings. However, with the pending acquisition by Medtronic, we don't expect the results to have any impact on the current share price. While we think ATS Medical's product portfolio and early-stage transcatheter valve program offer compelling strategic value to any potential acquirer, with every passing day sans a competing bid, we think the likelihood of another suitor stepping is declining."
To see all the upgrades/downgrades on shares of ATSI, visit our Analyst Ratings page.
ATS Medical, Inc. (ATS) develops, manufactures and markets medical devices for the treatment of structural heart disease.
Piper analyst says, "ATS Medical reported Q1 sales of $18.6M, which were a little light relative to our expectations both in terms of sales and earnings. However, with the pending acquisition by Medtronic, we don't expect the results to have any impact on the current share price. While we think ATS Medical's product portfolio and early-stage transcatheter valve program offer compelling strategic value to any potential acquirer, with every passing day sans a competing bid, we think the likelihood of another suitor stepping is declining."
To see all the upgrades/downgrades on shares of ATSI, visit our Analyst Ratings page.
ATS Medical, Inc. (ATS) develops, manufactures and markets medical devices for the treatment of structural heart disease.
You May Also Be Interested In
- UPDATE: UBS Downgrades Wisconsin Energy (WEC) to Neutral; Taking Some Off The Table
- Nomura Securities Maintains a 'Neutral' on Tiffany & Co. (TIF); Cutting Estimates and Price Target
- Goldman Sachs Downgrades Raytheon (RTN) to Sell; Risk To Back-End Loaded 2012
Create E-mail Alert Related Categories
DowngradesRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
